Article

Discovery of highly potent small molecule pan-coronavirus fusion inhibitors

2023-01-18

Abstract excerpt

<h4>ABSTRACT</h4> The unprecedented pandemic of COVID-19, caused by a novel coronavirus, SARS-CoV-2, has led to massive human suffering, death, and economic devastation worldwide. The virus is mutating fast to more transmissible and infectious variants. The Delta variant (B.1.617.2), initially identified in India, and the omicron variant (BA.4 and BA.5) have spread worldwide. In addition, recently alarming antibo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8bf544f0-b245-53cd-948d-12d87f226f8a
DOI: 10.1101/2023.01.17.524492

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Discovery of highly potent small molecule pan-coronavirus fusion inhibitorsDOI 10.1101/2023.01.17.524492Read

Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK (Alpha), South Africa (Beta), and India (Delta)Semantic proximity Read

Recent advances in small-molecular therapeutics for COVID-19Semantic proximity Read

Preclinical and Clinical Study of Efficacy of NAOQ19 against SARS-COV2: A Comprehensive EvaluationSemantic proximity Read

Druggable targets and therapeutic development for COVID-19Semantic proximity Read

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Bio-Logical and Pharmacological ProfilingSemantic proximity Read

Significant Broad Spectrum Antiviral activity of Bi121 Against Different Variants of SARS-CoV-2Semantic proximity Read

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Semantic proximity Read

Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluationSemantic proximity Read

Identification of Broad Anti-Coronavirus Chemical Agents for Repurposing Against SARS-CoV-2 and Variants of ConcernSemantic proximity Read

High throughput screening identifies broad-spectrum Coronavirus entry inhibitorsSemantic proximity Read

A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variantsSemantic proximity Read

Molecular Mechanisms of the Medicines for COVID-19Semantic proximity Read